The role of menin in hematopoiesis

Advances in Experimental Medicine and Biology

Volumn 668, Issue , 2009, Pages 51-57

  Hess, Jay L ^a   Maillard, Ivan ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

METHIONINE; MIXED LINEAGE LEUKEMIA PROTEIN; HYBRID PROTEIN; MEN1 PROTEIN, HUMAN; MLL PROTEIN, HUMAN; MULTIPROTEIN COMPLEX; ONCOPROTEIN;

ARTICLE; CELL IMMORTALIZATION; GENE; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HOX GENE; LEUKEMOGENESIS; MEIS1 GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; ANIMAL; GENETICS; HUMAN; LEUKEMIA; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; HEMATOPOIESIS; HUMANS; LEUKEMIA; MULTIPROTEIN COMPLEXES; MYELOID-LYMPHOID LEUKEMIA PROTEIN; PROTO-ONCOGENE PROTEINS; RECOMBINANT FUSION PROTEINS;

EID: 77950358917     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (47)

1. Felix CA. Secondary leukemias induced by topoisomerase-rargered drugs. Blochim Biophys Acta 1998; 1400:233-55. (Pubitemid 28475107)
2. Yokoyama A, Kitabayashi 1, Ayton PM et al. Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties. Blood 2002; 100:3710-8. (Pubitemid 35303943)
3. Nakamura T, Mori T, Tada Set al. ALL-I is a histone methyltransferase that assemblesa supercomplex of proteins involved in transcriptional regulation. Mol Cell 2002; 10:1119-28. (Pubitemid 35453829)
4. Birke M, Schreiner S, Garcia-Cuellar MPet al. The MT domain of the proto-oncoprotein MLL binds to CpG-containing DNA and discriminates against methylation. Nucleic Acids Res 2002; 30:958-65. (Pubitemid 34679664)
5. Ayton PM, Chen EH, Cleary ML. Binding to nonrnethylated CpG DNA is essential for target recognition, transacrivarion and myeloid transformation by an MLL oncoprotein. Mol Cell Bio 2004; 24:10470-8. (Pubitemid 39507883)
6. Schultz DC, Friedman JR, Rauscher FJ 3rd. Targeting histone deacetylase complexes via KRAB-zinc finger proteins : The PHD and bromodomains of KAP-1 form a cooperative unit that recruits a novel isoform of the Mi-2alpha subunit of NuRD. Genes Dev 2001; 15:428-43. (Pubitemid 32187004)
7. Fair K, Anderson M, Bulanova Eet al. Protein interactions of the MLL PHD fingers modulate MLL target gene regulation in human cells. Mol Cell Bioi 2001; 21:3589-97. (Pubitemid 32381794)
8. Filetici P, PO, Ballario P. The bromodomain : A chromatin browser? Front Biosci 2001; 6:866-76.
9. Milne TA, Briggs SD, Brock HWet al. MLL targets SET domain methyltransferase activity to hox gene promoters. Mol Cell 2002; 10:1107-17. (Pubitemid 35453828)
10. Milne TA, Dou Y,Martin MEet al. MLL associates specificallywith a subset of transcriptionally active target genes. Proc Nat Acad Sci USA 2005; 102:14765-70.
11. Ernst P, WangJ, Huang M et al. MLL and CREB bind cooperatively to the nuclear coactivator CREB-binding protein, Mol Cell Biol 2001; 21:2249-58. (Pubitemid 32222079)
12. Petruk S, Sedkov Y, Smith Set al. Trithorax and dCBP acting in a complex to maintain expression of a homeotic gene. Science 2001; 294:1331-4. (Pubitemid 33063097)
13. Dou Y, Milne TA, Tackett AJet al. Physical association and coordinate function of the H3 K4 methyltransferase MLLl and the H4 K16 acetyltransferaseMOE Cell 2005; 121:873-85. (Pubitemid 40806419)
14. Yokoyama A, Wang Z, WysockaJet al. Leukemia proto-oncoprotein MLL forms a SET1-like histone merhyltransferase complex with menin to regulate hox gene expression. Mol Cell Biol 2004; 24:5639-49. (Pubitemid 38787950)
15. Milne TA, Hughes CM, Lloyd Ret al. Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors, Proc Nat Acad Sci USA 2005; 102:749-54. (Pubitemid 40282737)
16. WysockaJ, Swigut T, Milne TA et al. WDR5 associates with histone H3 methylated at K4 and is essential for H3 K4 methylation and vertebrate development. Cell 2005; 121:859-72. (Pubitemid 40806418)
17. Agarwal SK, Lee Burns A, Sukhodolets KE et al. Molecular pathology of the MEN1 gene. Ann N Y Acad Sci 2004; 1014:189-98. (Pubitemid 38594805)
18. Agarwal SK, Guru SC, Heppner Cet al. Menin interacts with the API transcription factor lunD and represseslunD-Activated transcription, Cell 1999; 96:143-52. (Pubitemid 29044161)
19. Heppner C, Bilimoria KY, Agarwal SK et al. The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation. Oncogene 2001; 20:4917-25. (Pubitemid 32769781)
20. Hughes CM, Rozenblatt-Rosen O, Milne TAet al. Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. Mol Cell 2004; 13:587-97. (Pubitemid 38299385)
21. Yu BD, Hess JL, Horning SEet al. Altered hox expression and segmental identity in Mll-mutant mice.Nature 1995; 378:505-8.
22. Milne TA, Hughes CM, Lloyd Ret al. Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors, Proc Natl Acad Sci USA 2005; 102:749-54. (Pubitemid 40282737)
23. Kipl and p18INK4c. Proc Nat Acad Sci USA 2005; 102:14659-64. (Pubitemid 41457112)
24. Scacheri PC, Davis S, Odorn DTet al. Genome-wide Analysis of menin binding provides insights into MEN1 tumorigenesis. PLoS Genetics 2006; 2:e5.I.
25. Schnepp RW; Chen YX, Wang Het al. Mutation of tumor suppressor gene menl acutely enhances proliferation of pancreatic islet cells. Cancer Res 2006; 66(11) :5707-15. (Pubitemid 43927123)
26. Hess JL, Yu BD, Li Bet al. Defects in yolk sac hemaropoie sis in Mil-null embr yos. Blood 1997; 90:1799-806.
27. Yagi H, Deguchi K, Aono Aet al. Growth disturbance in feral liver hematopoiesis of Mil-mutant mice.Blood 1998; 92:108-17. (Pubitemid 28303182)
28. Ernst P, Fisher JK, AveryWet al. Definitive hematopoie sis requires the mixed-lineage leukemia gene.Dev Cell 2004; 6:437-43. (Pubitemid 38364574)
29. Jude CD, Climer L, Xu D et al. Unique and independent roles for MLL in adult hemaropoietic stem cells and progenirors, Cell Stem Cell 2007; 1:324-337. (Pubitemid 47355322)
30. McMahon KA, Hiew SYL, Hadjur Set al. Mil has a critical role in fetal and adult hematopoietic Stem cell self-renewal. Cell Stem Cell 2007; 1:338-345. (Pubitemid 47355325)
31. Bertolino P, Radovanovic I, Casse Het al. Genetic ablation of the tumor suppressor menin causes lethal ity at mid-gestation with defects in multiple organs. Mech Dev 2003: 120:549-60. (Pubitemid 36623317)
32. Crabtree JS, Scacheri PC, WardJMet al. Of mice and MENl: Insulinomas in a conditional mouse knockout. Mol Cell Biol 2003: 23:6075-85. (Pubitemid 37013087)
33. Chen Y-X, YanJ, Keeshan Ket al. The tumor suppressor menin regulates hematopo iesis and myeloid transformation by influencing hox gene expression. Proc Natl Acad Sci USA 2006: 103:1018-23. (Pubitemid 43212214)
34. Maillard 1, Chen Y, Tubbs ATet al. Menin regulates the function of hematopoietic stem cells and lymphoid progenirors, Blood 2007: 110:379a.
35. Lawrence HJ, Helgason CD, Sauvageau Get al. Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid and lymphoid hematopoiesis, Blood 1997; 89:1922-30. (Pubitemid 27132106)
36. Lawrence HJ, ChristensenJ, Fong Set al. Loss of expression of the hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells. Blood 2005; 106:3988-94. (Pubitemid 41739043)
37. Kroon E, KroslJ, Thorsteinsdottir U et al. Hoxa9 transforms primary bone marrow cells through specific collaboration with meisla bur not Pbxlb, EMBOJ 1998: 17:3714-25, (Pubitemid 28327389)
38. Magli Me. Largman C, Lawrence HJ. Effects of HOX homeobox genes in blood cell differentiation,J Cell Physiol1997; 173:168-77. (Pubitemid 27481125)
39. Lawrence HJ, Sauvageau G, Humphries RKet al. The role of HOX homeobox genes in normal and leukemic hematopoiesis. Stem Cells 1996: 14:281-9.I. (Pubitemid 26161610)
40. Pineault N, Helgason CD, Lawrence HJet al. Differential expression of hox, meisl and Pbxl genes in primitive cells throughour murine hematopoietic ontogeny. Exp Hernatol 2002: 30:49-57. (Pubitemid 34059217)
41. Armstrong SA, Staunton JE, Silverman LBet al. MLL tran slocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002; 30:41-7.
42. Rozovskaia T, Feinstein E, Mor Oet al. Upregulation of Meisl and HoxA9 in acute lymphocytic leukemias with the t(4:11) abnormality. Oncogene 2001: 20:874-8. (Pubitemid 32198181)
43. Yeoh EJ, Ross ME, Shurtleff SA et al. Classification, subtype discovery and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002; 1:133-43. (Pubitemid 41039160)
44. Nakamura T, Largaespada DA, ShaughnessyJD Jret al. Cooperative activation of hoxa and Pbxl-relared genes in murine myeloid leukaemias. Nat Genet 1996: 12:149-53. (Pubitemid 26051294)
45. MoskowJJ, Bullrich F, Huebner Ket al. Meisl, a PBXl-reiated homeobox gene involved in myeloid leukemia in BXH-2 mice. Mol Cell Biol 1995; 15:5434-43.
46. Ayron PM, Cleary ML. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins,Oncogene 2001; 20:5695-707, (Pubitemid 32928107)
47. Caslini C, YangZ, El-Osta Met al. Interaction ofMLL amino terminal sequences with menin is required for transformation. Cancer Res 2007: 67:7275-83. (Pubitemid 47206556)